Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery

• Status: Unknown status
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery : A Randomized Controlled Trial

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams Maternity Hospital
• Treatments: Misoprostol; Ranitidine; Ranitidine bismuth citrate

Criteria

Inclusion Criteria:

• singleton pregnancies

• women booked for elective C.S

• full term pregnancies

• primi gravida or previous one delivery ( either by spontaneous vaginal delivery or C.S )

Exclusion Criteria:

• blood disorders

• multiple pregnancy

• placenta previa

• polyhydramnios

• marked maternal anemia

• contraindications to prostaglandin e.g history of asthma , allergy to misoprostol

• previous 2 or more C.S